Jan M. Griffin

3.7k total citations · 1 hit paper
65 papers, 2.1k citations indexed

About

Jan M. Griffin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Jan M. Griffin has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Cardiology and Cardiovascular Medicine and 23 papers in Surgery. Recurrent topics in Jan M. Griffin's work include Amyloidosis: Diagnosis, Treatment, Outcomes (24 papers), Cardiac Structural Anomalies and Repair (18 papers) and Mechanical Circulatory Support Devices (16 papers). Jan M. Griffin is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (24 papers), Cardiac Structural Anomalies and Repair (18 papers) and Mechanical Circulatory Support Devices (16 papers). Jan M. Griffin collaborates with scholars based in United States, Australia and Italy. Jan M. Griffin's co-authors include Nir Uriel, Kevin J. Clerkin, Gabriel Sayer, J. Fried, Daniel Burkhoff, J. Raikhelkar, Amirali Masoumi, Deepa Kumaraiah, Sneha S. Jain and LeRoy E. Rabbani and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Jan M. Griffin

55 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID-19 and Cardiovascular Disease

2020 1.2k citations Kevin J. Clerkin, J. Fried et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan M. Griffin United States	18	810	527	518	478	399	65	2.1k
Amirali Masoumi United States	22	1.2k 1.5×	517 1.0×	710 1.4×	701 1.5×	379 0.9×	66	3.1k
Ling Zhou China	19	1.0k 1.3×	440 0.8×	377 0.7×	608 1.3×	405 1.0×	59	2.3k
Riccardo M. Inciardi Italy	19	1.1k 1.4×	172 0.3×	1.3k 2.4×	722 1.5×	255 0.6×	99	2.5k
Ran Luo China	18	1.6k 1.9×	172 0.3×	85 0.2×	659 1.4×	646 1.6×	55	2.6k
Yichun Cheng China	14	1.6k 1.9×	178 0.3×	76 0.1×	651 1.4×	608 1.5×	37	2.5k
Yoon‐Kyoung Sung South Korea	30	172 0.2×	301 0.6×	145 0.3×	91 0.2×	299 0.7×	221	3.3k
Yunhe Zhao China	8	1.0k 1.3×	257 0.5×	224 0.4×	586 1.2×	346 0.9×	18	1.8k
Gaurav Aggarwal United States	19	857 1.1×	327 0.6×	93 0.2×	608 1.3×	531 1.3×	66	2.0k
Hong Yu China	19	389 0.5×	143 0.3×	131 0.3×	226 0.5×	155 0.4×	92	1.5k
Zhe Dai China	16	571 0.7×	202 0.4×	97 0.2×	365 0.8×	340 0.9×	51	1.5k

Countries citing papers authored by Jan M. Griffin

Since Specialization

Citations

This map shows the geographic impact of Jan M. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan M. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan M. Griffin more than expected).

Fields of papers citing papers by Jan M. Griffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan M. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan M. Griffin. The network helps show where Jan M. Griffin may publish in the future.

Co-authorship network of co-authors of Jan M. Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Jan M. Griffin. A scholar is included among the top collaborators of Jan M. Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan M. Griffin. Jan M. Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grodin, Justin L., Anand Gupta, Julia Kozlitina, et al.. (2025). Risk for Heart Failure and Atrial Fibrillation Across the Lifespan for Carriers of the Amyloidogenic p.V142I TTR Variant. Circulation Genomic and Precision Medicine. 18(4). e004911–e004911. 1 indexed citations

Ambardekar, Amrut V., Richard K. Cheng, Jan M. Griffin, et al.. (2025). Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance. Journal of the American College of Cardiology. 87(5). 549–565.

Clerkin, Kevin J., Lorenzo R. Sewanan, Jan M. Griffin, et al.. (2024). Added prognostic value of visually estimated coronary artery calcium among heart transplant recipients. The Journal of Heart and Lung Transplantation. 43(11). 1795–1805. 2 indexed citations

Rosenblum, Hannah, Jan M. Griffin, Masatoshi Minamisawa, et al.. (2023). Effect of Patisiran on Stroke Volume in Hereditary Transthyretin-Mediated Amyloidosis: Insights from Pressure–Volume Analysis of the APOLLO Study. European Journal of Heart Failure. 25(5). 727–736. 6 indexed citations

Pavlovic, Noelle, Jan M. Griffin, David R. Okada, et al.. (2022). Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation. Respiratory Medicine. 198. 106864–106864. 17 indexed citations

Bhattacharya, Priyanka, et al.. (2022). TAFAMIDIS EFFECTIVENESS IN WILD-TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS BY MAYO STAGING. Journal of the American College of Cardiology. 79(9). 306–306. 6 indexed citations

Topkara, Veli K., Kevin J. Clerkin, J. Fried, et al.. (2021). Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem?. Circulation Heart Failure. 14(6). e007916–e007916. 21 indexed citations

Park, Elizabeth, Jan M. Griffin, & Joan M. Bathon. (2021). Myocardial Dysfunction and Heart Failure in Rheumatoid Arthritis. Arthritis & Rheumatology. 74(2). 184–199. 26 indexed citations

Bracamonte‐Baran, William, Nisha A. Gilotra, Taejoon Won, et al.. (2021). Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8 ⁺ T-Cell Infiltration After Heart Transplantation. Circulation Heart Failure. 14(10). 14 indexed citations

10.

Gilotra, Nisha A., Jan M. Griffin, Noelle Pavlovic, et al.. (2021). Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review. Journal of Cardiac Failure. 28(1). 113–132. 42 indexed citations

11.

Griffin, Jan M., Hannah Rosenblum, Kevin J. Clerkin, et al.. (2021). Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies. The Journal of Heart and Lung Transplantation. 41(2). 199–207. 9 indexed citations

12.

Clerkin, Kevin J., Amirali Masoumi, Yuji Kaku, et al.. (2021). AORTIC ROOT THROMBOSIS IN PATIENTS WITH HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICES. Journal of the American College of Cardiology. 77(18). 834–834. 1 indexed citations

13.

Kennel, Peter J., Hannah Rosenblum, Kelly Axsom, et al.. (2021). Remote Cardiac Monitoring in Patients With Heart Failure. JAMA Cardiology. 7(5). 556–556. 28 indexed citations

14.

Batra, Jaya, Hannah Rosenblum, Ersilia M. DeFilippis, et al.. (2020). Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure–Volume Analysis. Journal of Cardiac Failure. 27(1). 67–74. 20 indexed citations

15.

Michelis, Katherine C., Lin Zhong, W.H. Wilson Tang, et al.. (2020). Durable Mechanical Circulatory Support in Patients With Amyloid Cardiomyopathy. Circulation Heart Failure. 13(12). e007931–e007931. 18 indexed citations

16.

Batra, Jaya, et al.. (2020). SEX DIFFERENCES IN THE PHENOTYPE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS DUE TO VAL122ILE MUTATIONS: INSIGHTS FROM NON-INVASIVE PRESSURE-VOLUME ANALYSIS. Journal of the American College of Cardiology. 75(11). 876–876. 1 indexed citations

17.

Griffin, Jan M., Kevin J. Clerkin, J. Fried, et al.. (2020). Concordance between Coronary Artery Calcium and Coronary Angiography in the Detection of Cardiac Allograft Vasculopathy in Post Heart Transplant Patients. The Journal of Heart and Lung Transplantation. 39(4). S246–S246. 2 indexed citations

18.

Poterucha, Timothy J., Pierre Elias, Sabahat Bokhari, et al.. (2020). Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate. JACC. Cardiovascular imaging. 14(6). 1221–1231. 63 indexed citations

19.

Griffin, Jan M., et al.. (2018). Metastatic amelanotic melanoma with cardiac involvement: A case report. Journal of Cardiology Cases. 19(2). 59–61. 1 indexed citations

20.

Stuart, Elnora W., et al.. (2013). Have “Millennials” Embraced Digital Advertising as They Have Embraced Digital Media?. Journal of Promotion Management. 19(5). 652–673. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact